Main
>
ONCOLOGY (**)
>
Leukemia>Lymphocytic>Chronic ***
>
Treatment
>
USA. G. RituxiMAb+Hyaluronidase
>
(*) USA Approval Date: 2017. 06.22
(*) USA Approval Date: 2017. 06.22's products
This section has no products